IBDEI0L3 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26682,1,3,0)
 ;;=3^Delirium,Other Specified
 ;;^UTILITY(U,$J,358.3,26682,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,26682,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,26683,0)
 ;;=R41.0^^71^1116^16
 ;;^UTILITY(U,$J,358.3,26683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26683,1,3,0)
 ;;=3^Delirium,Unspec
 ;;^UTILITY(U,$J,358.3,26683,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,26683,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,26684,0)
 ;;=G31.09^^71^1116^20
 ;;^UTILITY(U,$J,358.3,26684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26684,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,26684,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,26684,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,26685,0)
 ;;=F02.81^^71^1116^36
 ;;^UTILITY(U,$J,358.3,26685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26685,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26685,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26685,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26686,0)
 ;;=F02.80^^71^1116^37
 ;;^UTILITY(U,$J,358.3,26686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26686,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26686,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26686,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26687,0)
 ;;=F02.81^^71^1116^42
 ;;^UTILITY(U,$J,358.3,26687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26687,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26687,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26687,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26688,0)
 ;;=F02.80^^71^1116^43
 ;;^UTILITY(U,$J,358.3,26688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26688,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26688,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26688,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26689,0)
 ;;=G31.84^^71^1116^58
 ;;^UTILITY(U,$J,358.3,26689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26689,1,3,0)
 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
 ;;^UTILITY(U,$J,358.3,26689,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26689,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26690,0)
 ;;=F02.81^^71^1116^26
 ;;^UTILITY(U,$J,358.3,26690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26690,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26690,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26690,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26691,0)
 ;;=F02.80^^71^1116^27
 ;;^UTILITY(U,$J,358.3,26691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26691,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26691,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26691,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26692,0)
 ;;=G31.84^^71^1116^59
 ;;^UTILITY(U,$J,358.3,26692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26692,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
 ;;^UTILITY(U,$J,358.3,26692,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26692,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26693,0)
 ;;=F02.81^^71^1116^28
 ;;^UTILITY(U,$J,358.3,26693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26693,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26693,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26693,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26694,0)
 ;;=F02.80^^71^1116^29
 ;;^UTILITY(U,$J,358.3,26694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26694,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26694,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26694,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26695,0)
 ;;=G31.84^^71^1116^60
 ;;^UTILITY(U,$J,358.3,26695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26695,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HUNTINGTON'S DISEASE
 ;;^UTILITY(U,$J,358.3,26695,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26695,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26696,0)
 ;;=G31.83^^71^1116^23
 ;;^UTILITY(U,$J,358.3,26696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26696,1,3,0)
 ;;=3^Lewy Body Disease
 ;;^UTILITY(U,$J,358.3,26696,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,26696,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,26697,0)
 ;;=F02.81^^71^1116^52
 ;;^UTILITY(U,$J,358.3,26697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26697,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26697,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26697,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26698,0)
 ;;=F02.80^^71^1116^53
 ;;^UTILITY(U,$J,358.3,26698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26698,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26698,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26698,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26699,0)
 ;;=F02.81^^71^1116^54
 ;;^UTILITY(U,$J,358.3,26699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26699,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26699,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26699,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26700,0)
 ;;=F02.80^^71^1116^55
 ;;^UTILITY(U,$J,358.3,26700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26700,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26700,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26700,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26701,0)
 ;;=G31.84^^71^1116^66
 ;;^UTILITY(U,$J,358.3,26701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26701,1,3,0)
 ;;=3^Mild Neurocog D/O w/ LEWY BODIES
 ;;^UTILITY(U,$J,358.3,26701,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26701,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26702,0)
 ;;=F02.81^^71^1116^30
 ;;^UTILITY(U,$J,358.3,26702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26702,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26702,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26702,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26703,0)
 ;;=F02.80^^71^1116^31
 ;;^UTILITY(U,$J,358.3,26703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26703,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26703,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26703,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26704,0)
 ;;=G31.84^^71^1116^61
 ;;^UTILITY(U,$J,358.3,26704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26704,1,3,0)
 ;;=3^Mild Neurocog D/O d/t MULTIPLE ETIOLOGIES
 ;;^UTILITY(U,$J,358.3,26704,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26704,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26705,0)
 ;;=G90.3^^71^1116^67
 ;;^UTILITY(U,$J,358.3,26705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26705,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,26705,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,26705,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,26706,0)
 ;;=F02.81^^71^1116^38
 ;;^UTILITY(U,$J,358.3,26706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26706,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26706,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26706,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26707,0)
 ;;=F02.80^^71^1116^39
 ;;^UTILITY(U,$J,358.3,26707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26707,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26707,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26707,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26708,0)
 ;;=F02.81^^71^1116^44
 ;;^UTILITY(U,$J,358.3,26708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26708,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26708,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26708,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26709,0)
 ;;=F02.80^^71^1116^45
 ;;^UTILITY(U,$J,358.3,26709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26709,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26709,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26709,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26710,0)
 ;;=G31.84^^71^1116^62
 ;;^UTILITY(U,$J,358.3,26710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26710,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,26710,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26710,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26711,0)
 ;;=A81.9^^71^1116^71
 ;;^UTILITY(U,$J,358.3,26711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26711,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,26711,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,26711,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,26712,0)
 ;;=F02.81^^71^1116^32
 ;;^UTILITY(U,$J,358.3,26712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26712,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,26712,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,26712,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,26713,0)
 ;;=F02.80^^71^1116^33
 ;;^UTILITY(U,$J,358.3,26713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26713,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,26713,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,26713,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,26714,0)
 ;;=G31.84^^71^1116^63
 ;;^UTILITY(U,$J,358.3,26714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26714,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,26714,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,26714,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,26715,0)
 ;;=S06.2X9S^^71^1116^74
 ;;^UTILITY(U,$J,358.3,26715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26715,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
